Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2011

01.12.2011 | Breast Oncology

Needle Versus Excisional Biopsy for Noninvasive and Invasive Breast Cancer: Report from the National Cancer Data Base, 2003–2008

verfasst von: Richelle T. Williams, MD, Katharine Yao, MD, Andrew K. Stewart, MA, David J. Winchester, MD, Mary Turk, Addie Gorchow, MBA, Nora Jaskowiak, MD, David P. Winchester, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Needle biopsy to diagnose breast cancer may soon become a quality measure for which hospitals are held accountable. This study examines the utilization of needle versus excisional biopsy in a contemporary cohort of patients and identifies factors associated with biopsy type.

Methods

Women with nonmetastatic, clinical Tis–T3 breast cancers diagnosed between 2003 and 2008 were selected from the National Cancer Data Base, which captures information from ~79% of breast cancers in the United States. Patients whose cancer was diagnosed by needle biopsy (fine-needle aspiration or core) were compared with patients diagnosed via excision, analyzing patient, hospital, and tumor characteristics. Logistic regression was used to identify important predictors of biopsy type.

Results

Of 373,837 patients, 303,677 (81.2%) underwent needle biopsy while 70,160 (18.8%) had excisional biopsy to diagnose their cancer. The needle biopsy rate increased from 73.8 to 86.7% whereas excisional biopsy declined from 26.2 to 13.3% over the study period (P < 0.001). In 2008, patients were statistically significantly more likely to undergo excisional biopsy if they had stage 0 disease; were treated at low-volume (<25 cases/year), community, or Atlantic census region hospitals; were <40 years old at diagnosis; were less educated; or were Asian/Pacific Islander (P < 0.001). The median rate of needle biopsy at high-volume hospitals (≥140 cases/year) was 89.6%.

Conclusion

The use of needle biopsy is increasing. Tumor stage, hospital volume, and hospital location were the most statistically significant predictors of biopsy type. Rates of needle biopsy at high-volume hospitals suggest that appropriate utilization of this preferred diagnostic method should approach 90%.
Literatur
2.
Zurück zum Zitat Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in surveillance, epidemiology, and end results–medicare data. Cancer. 2009;115:716–24.PubMedCrossRef Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in surveillance, epidemiology, and end results–medicare data. Cancer. 2009;115:716–24.PubMedCrossRef
3.
Zurück zum Zitat Hatmaker AR, Donahue RM, Tarpley JL, Pearson AS. Cost-effective use of breast biopsy techniques in a Veterans health care system. Am J Surg. 2006;192:e37–41.PubMedCrossRef Hatmaker AR, Donahue RM, Tarpley JL, Pearson AS. Cost-effective use of breast biopsy techniques in a Veterans health care system. Am J Surg. 2006;192:e37–41.PubMedCrossRef
4.
Zurück zum Zitat Ghosh K, Melton LJ 3rd, Suman VJ, et al. Breast biopsy utilization: a population-based study. Arch Intern Med. 2005;165:1593–8.PubMedCrossRef Ghosh K, Melton LJ 3rd, Suman VJ, et al. Breast biopsy utilization: a population-based study. Arch Intern Med. 2005;165:1593–8.PubMedCrossRef
5.
Zurück zum Zitat Bruening W, Fontanarosa J, Tipton K, Treadwell JR, Launders J, Schoelles K. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010;152:238–46.PubMed Bruening W, Fontanarosa J, Tipton K, Treadwell JR, Launders J, Schoelles K. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010;152:238–46.PubMed
6.
Zurück zum Zitat Collins LC, Connolly JL, Page DL, et al. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004;28:126–31.PubMedCrossRef Collins LC, Connolly JL, Page DL, et al. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004;28:126–31.PubMedCrossRef
7.
Zurück zum Zitat Shah VI, Raju U, Chitale D, Deshpande V, Gregory N, Strand V. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 consecutive cases of missed breast cancer. Cancer. 2003;97:1824–31.PubMedCrossRef Shah VI, Raju U, Chitale D, Deshpande V, Gregory N, Strand V. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 consecutive cases of missed breast cancer. Cancer. 2003;97:1824–31.PubMedCrossRef
8.
Zurück zum Zitat Verkooijen HM, Peeters PH, Buskens E, et al. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer. 2000;82:1017–21.PubMedCrossRef Verkooijen HM, Peeters PH, Buskens E, et al. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer. 2000;82:1017–21.PubMedCrossRef
9.
Zurück zum Zitat Al-Attar MA, Michell MJ, Ralleigh G, et al. The impact of image guided needle biopsy on the outcome of mammographically detected indeterminate microcalcification. Breast. 2006;15:635–9.PubMedCrossRef Al-Attar MA, Michell MJ, Ralleigh G, et al. The impact of image guided needle biopsy on the outcome of mammographically detected indeterminate microcalcification. Breast. 2006;15:635–9.PubMedCrossRef
10.
Zurück zum Zitat Landercasper J, Tafra L. The relationship between quality and cost during the perioperative breast cancer episode of care. Breast. 2010;19:289–96.PubMedCrossRef Landercasper J, Tafra L. The relationship between quality and cost during the perioperative breast cancer episode of care. Breast. 2010;19:289–96.PubMedCrossRef
11.
Zurück zum Zitat Golub RM, Bennett CL, Stinson T, Venta L, Morrow M. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. 2004;22:2430–7.PubMedCrossRef Golub RM, Bennett CL, Stinson T, Venta L, Morrow M. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. 2004;22:2430–7.PubMedCrossRef
12.
Zurück zum Zitat Liberman L, Kaplan JB. Percutaneous core biopsy of nonpalpable breast lesions: utility and impact on cost of diagnosis. Breast Dis. 2001;13:49–57.PubMed Liberman L, Kaplan JB. Percutaneous core biopsy of nonpalpable breast lesions: utility and impact on cost of diagnosis. Breast Dis. 2001;13:49–57.PubMed
13.
Zurück zum Zitat Logan-Young W, Dawson AE, Wilbur DC, et al. The cost-effectiveness of fine-needle aspiration cytology and 14-gauge core needle biopsy compared with open surgical biopsy in the diagnosis of breast carcinoma. Cancer. 1998;82:1867–73.PubMedCrossRef Logan-Young W, Dawson AE, Wilbur DC, et al. The cost-effectiveness of fine-needle aspiration cytology and 14-gauge core needle biopsy compared with open surgical biopsy in the diagnosis of breast carcinoma. Cancer. 1998;82:1867–73.PubMedCrossRef
14.
Zurück zum Zitat King TA, Cederbom GJ, Champaign JL, et al. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning. Am J Surg. 1998;176:497–501.PubMedCrossRef King TA, Cederbom GJ, Champaign JL, et al. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning. Am J Surg. 1998;176:497–501.PubMedCrossRef
15.
Zurück zum Zitat Whitten TM, Wallace TW, Bird RE, Turk PS. Image-guided core biopsy has advantages over needle localization biopsy for the diagnosis of nonpalpable breast cancer. Am Surg. 1997;63:1072–7.PubMed Whitten TM, Wallace TW, Bird RE, Turk PS. Image-guided core biopsy has advantages over needle localization biopsy for the diagnosis of nonpalpable breast cancer. Am Surg. 1997;63:1072–7.PubMed
16.
Zurück zum Zitat Geller BM, Oppenheimer RG, Mickey RM, Worden JK. Patient perceptions of breast biopsy procedures for screen-detected lesions. Am J Obstet Gynecol. 2004;190:1063–9.PubMedCrossRef Geller BM, Oppenheimer RG, Mickey RM, Worden JK. Patient perceptions of breast biopsy procedures for screen-detected lesions. Am J Obstet Gynecol. 2004;190:1063–9.PubMedCrossRef
17.
Zurück zum Zitat Verkooijen HM, Buskens E, Peeters PH, Borel Rinkes IH, de Koning HJ, van Vroonhoven TJ; COBRA Study Group. Diagnosing non-palpable breast disease: short-term impact on quality of life of large-core needle biopsy versus open breast biopsy. Surg Oncol. 2002;10:177–81.PubMedCrossRef Verkooijen HM, Buskens E, Peeters PH, Borel Rinkes IH, de Koning HJ, van Vroonhoven TJ; COBRA Study Group. Diagnosing non-palpable breast disease: short-term impact on quality of life of large-core needle biopsy versus open breast biopsy. Surg Oncol. 2002;10:177–81.PubMedCrossRef
19.
Zurück zum Zitat Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85:1–3.PubMedCrossRef Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85:1–3.PubMedCrossRef
20.
Zurück zum Zitat Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15: 683–90.PubMedCrossRef Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15: 683–90.PubMedCrossRef
21.
Zurück zum Zitat Fritz A, Percy C, Jack A, et al., editors. ICD-O: international classification of diseases for oncology. 3rd ed. Geneva: World Health Organization, 2000. Fritz A, Percy C, Jack A, et al., editors. ICD-O: international classification of diseases for oncology. 3rd ed. Geneva: World Health Organization, 2000.
22.
Zurück zum Zitat Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M., editors. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M., editors. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
24.
Zurück zum Zitat Dayo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;44:613–9.CrossRef Dayo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;44:613–9.CrossRef
26.
Zurück zum Zitat Pocock B, Taback B, Klein L, Joseph KA, El-Tamer M. Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol. 2009;16:1108–11.PubMedCrossRef Pocock B, Taback B, Klein L, Joseph KA, El-Tamer M. Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol. 2009;16:1108–11.PubMedCrossRef
27.
Zurück zum Zitat Olaya W, Bae W, Wong J, et al. Are percutaneous biopsy rates a reasonable quality measure in breast cancer management? Ann Surg Oncol. 2010;17(Suppl. 3):268–72.PubMedCrossRef Olaya W, Bae W, Wong J, et al. Are percutaneous biopsy rates a reasonable quality measure in breast cancer management? Ann Surg Oncol. 2010;17(Suppl. 3):268–72.PubMedCrossRef
28.
Zurück zum Zitat Holloway CM, Saskin R, Paszat L. Geographic variation and physician specialization in the use of percutaneous biopsy for breast cancer diagnosis. Can J Surg. 2008;51:453–63.PubMed Holloway CM, Saskin R, Paszat L. Geographic variation and physician specialization in the use of percutaneous biopsy for breast cancer diagnosis. Can J Surg. 2008;51:453–63.PubMed
29.
Zurück zum Zitat Clarke-Pearson EM, Jacobson AF, Boolbol SK, et al. Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique. J Am Coll Surg. 2009;208:75–8.PubMedCrossRef Clarke-Pearson EM, Jacobson AF, Boolbol SK, et al. Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique. J Am Coll Surg. 2009;208:75–8.PubMedCrossRef
Metadaten
Titel
Needle Versus Excisional Biopsy for Noninvasive and Invasive Breast Cancer: Report from the National Cancer Data Base, 2003–2008
verfasst von
Richelle T. Williams, MD
Katharine Yao, MD
Andrew K. Stewart, MA
David J. Winchester, MD
Mary Turk
Addie Gorchow, MBA
Nora Jaskowiak, MD
David P. Winchester, MD
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1808-y

Weitere Artikel der Ausgabe 13/2011

Annals of Surgical Oncology 13/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.